Guardant Health, Inc.
corporate_fare Company Profile
Guardant Health, Inc. (NASDAQ:GH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 24 items for GH at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Guardant Health's InfinityAI Evidence Aids Enhertu® Approval in Japan for HER2+ Tumors
- Guardant Health Reports Strong 2025 Revenue Growth, Secures $287M Legal Win, and Advances Key Product Approvals
- Guardant Health Reports Strong Q4 & FY25 Results, Provides Robust 2026 Revenue Guidance
- Guardant Health Reports Strong Preliminary Q4 and Full Year 2025 Results with Accelerating Revenue and Shield Growth
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$982.02M
Net Income
-$416.28M
Diluted EPS
-$3.32
Op. Cash Flow
-$184.76M
Free Cash Flow
-$233.07M
Gross Profit
$633.01M
Operating Income
-$437.25M
Cash & Equivalents
$378.2M
Total Debt
$1.5B
Debt / Equity
-15.14×
Net Margin
-42.4%
Shares Outstanding
130.64M sh
Source: 10-K · filed 2026-02-19 · accession 0001576280-26-000013
show_chartPrice Chart
Loading chart...
feed GH - Filings & News (Page 2)
GH
Mar 30, 2026, 10:11 AM EDT
Price at Filing:
$86.72
Real-time Price:
$145.83
Change:
+$59.11 (+68%)
Market Cap:
$19.729B
GH
Feb 19, 2026, 5:14 PM EST
Price at Filing:
$110.25
Real-time Price:
$145.83
Change:
+$35.58 (+32%)
Market Cap:
$19.729B
GH
Feb 19, 2026, 4:12 PM EST
Price at Filing:
$106.00
Real-time Price:
$145.83
Change:
+$39.83 (+38%)
Market Cap:
$19.729B
GH
Jan 12, 2026, 6:04 AM EST
Price at Filing:
$111.40
Real-time Price:
$145.83
Change:
+$34.43 (+31%)
Market Cap:
$19.729B